Secondary and tertiary transmission of vaccinia virus from us military service member

Emerging Infectious Diseases

Volumn 17, Issue 4, 2011, Pages 718-721

  Young, Gregory E ^a   Hidalgo, Christina M ^a   Sullivan Frohm, Ann ^a   Schulte, Cynthia ^a   Davis, Stephen ^a   Kelly Cirino, Cassandra ^a   Egan, Christina ^a   Wilkins, Kimberly ^b   Emerson, Ginny L ^b   Noyes, Kimberly ^a   Blog, Debra ^a  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; HERPES ZOSTER IMMUNOGLOBULIN; SMALLPOX VACCINE; TRIFLURIDINE;

ADULT; ARTHRALGIA; ARTICLE; BLEPHARITIS; CASE REPORT; CHILL; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG FEVER; ECZEMA; ERYTHEMA; EXUDATE; EYE INJURY; FACE INJURY; FEMALE; FOLLOW UP; HUMAN; IMPETIGO; INFECTION CONTROL; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MILITARY SERVICE; MOLLUSCIPOXVIRUS; NECK INJURY; PRURITUS; SKIN DEFECT; SLIT LAMP; TREATMENT OUTCOME; UNITED STATES; VACCINIA VIRUS; VACCINIA VIRUS INFECTION; VIRUS INFECTION; VIRUS TRANSMISSION; WRESTLING;

ADULT; FEMALE; HUMANS; INFECTION CONTROL; MALE; MILITARY PERSONNEL; SKIN; SMALLPOX VACCINE; UNITED STATES; VACCINIA; VACCINIA VIRUS; YOUNG ADULT;

EID: 79953709111     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1704.101316     Document Type: Article

References (9)

1. Casey C, Vellozzi C, Mootrey GT, Chapman LE, McCauley M, Roper MH, et al. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep. 2006;55(RR-1):1-16.
2. Rotz LD, Dotson DA, Damon IK, Becher JA; Advisory Committee on Immunization Practices. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep. 2001;50(RR-10):1-25.
3. Vaccine Healthcare Centers Network. Contact transmission fact sheet [cited 2010 Nov 30]. http://www.vhcinfo.org/healthcareProfessionals.asp?page=smallpox_transoverview&title=Smallpox
4. Cono J, Casey CG, Bell DM, Centers for Disease Control and Prevention. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR Recomm Rep. 2003;52(No.RR-4):1-28.
5. Centers for Disease Control and Prevention. Medical management of smallpox (vaccinia) vaccine adverse reactions: vaccinia immune globulin and cidofovir [cited 2010 Nov 29]. http://emergency.cdc.gov/agent/smallpox/vaccination/mgmt-adv-reactions.asp
6. Ropp SL, Jin Q, Knight JC, Massung RF, Esposito JJ. PCR strategy for identifi cation and differentiation of small pox and other orthopoxviruses. J Clin Microbiol. 1995;33:2069-76.
7. Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, et al. Recommendations for using smallpox vaccine in a prevent vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003;52:1-16.
8. Centers for Disease Control and Prevention. CDC interim guidance for revaccination of eligible persons who participated in the US civilian smallpox preparedness and response program. October 2008 [cited 2010 Nov 29]. http://emergency.cdc.gov/agent/smallpox/revaxmemo.asp?s_cid=EmergencyPreparedness1e
9. Strikas RA, Neff LJ, Rotz L, Cono J, Knutson D, Henderson J, et al. US Civilian Smallpox Preparedness and Response Program, 2003. Clin Infect Dis. 2008;46:S157-67. DOI: 10.1086/524751